CCDC30 (coiled-coil domain containing 30) is a gene located on chromosome 1 that encodes a protein containing a coiled-coil domain. While its primary biological function remains incompletely characterized, CCDC30 has emerged as a significant player in cancer biology, particularly through gene fusion events. The most well-established role of CCDC30 is as a fusion partner with the ROS1 receptor tyrosine kinase in thyroid carcinomas. In the CCDC30-ROS1 fusion, the coiled-coil domain of CCDC30 is fused to the N-terminal kinase domain of ROS1, with CCDC30 postulated to drive constitutive activation of ROS1 kinase 1. This fusion has been identified in papillary thyroid carcinomas with aggressive clinical presentations, including extensive lymphovascular invasion, extrathyroidal extension, and cervical lymph node metastasis 2. In pediatric papillary thyroid carcinoma, CCDC30-ROS1 represents a rare but recurrent fusion that induces MAPK pathway activation and promotes cell proliferation; these effects are suppressible by ROS1-targeted tyrosine kinase inhibitors 3. Additionally, CCDC30 polymorphisms have been associated with asthma exacerbations in smoking asthmatics, suggesting potential roles in inflammatory airway disease 4. These findings indicate that CCDC30 participates in both oncogenic transformation and immune-inflammatory pathways, making it a candidate for therapeutic intervention in ROS1-rearranged thyroid malignancies.